NCT07190365 Goal-oriented Telehealth Rehabilitation of Executive Functioning for Veterans With Chronic TBI
| NCT ID | NCT07190365 |
| Status | Recruiting |
| Phase | — |
| Sponsor | VA Office of Research and Development |
| Condition | Mild to Moderate Traumatic Brain Injury |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2026-04-01 |
| Primary Completion | 2030-03-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2026-04-01 with a primary completion date of 2030-03-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Provision of interventions that address cognitive and emotional problems faced by Veterans with history of TBI pursuing community reintegration is an important concern for VA. Using telerehabilitation, the current project will help determine whether goal-directed training of attentional control functions via personally relevant activities will improve community integration for Veterans with history of TBI and cognitive difficulties. Findings may guide rehabilitation training towards providing services to maximize success in attaining complex functional goals in which Veterans can engage in skill strengthening 'where they are' (any location).
Eligibility Criteria
Inclusion Criteria: * History of mild to moderate TBI \> 6 months ago * Cognitive difficulties affecting daily functioning * Age 18-65 * Veteran * At least 12th grade education or equivalent \* Interested in improving community reintegration Exclusion Criteria: * Amnesic/Severe memory problems * Active Substance Abuse/Dependence * Medical condition that may affect mental status/disrupt study participation * Active psychotropic medication changes
Contact & Investigator
Tatjana Novakovic-Agopian, PhD
PRINCIPAL INVESTIGATOR
VA Palo Alto Health Care System, Palo Alto, CA
Frequently Asked Questions
Who can join the NCT07190365 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Mild to Moderate Traumatic Brain Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07190365 currently recruiting?
Yes, NCT07190365 is actively recruiting participants. Contact the research team at tatjana.novakovic-agopian@va.gov for enrollment information.
Where is the NCT07190365 trial being conducted?
This trial is being conducted at Palo Alto, United States.
Who is sponsoring the NCT07190365 clinical trial?
NCT07190365 is sponsored by VA Office of Research and Development. The principal investigator is Tatjana Novakovic-Agopian, PhD at VA Palo Alto Health Care System, Palo Alto, CA. The trial plans to enroll 80 participants.